News Jan 30, 2018 Polyphor develops inhaled antibiotics The pharmaceutical company Polyphor is launching an inhaled formulation of its innovative antibiotic Murepavadi. It is also supporting a large-sc...
News Jan 30, 2018 Sensor measures fat burning in real time Zurich researchers have developed a sensor that, by means of a breathalyser, measures when the body starts burning fat. The goal is to integrate ...
News Jan 30, 2018 Empa develops glue for wounds Researchers at the Federal Laboratories for Materials Science and Technology (Empa) have developed a nanoparticle-based tissue glue that can be u...
News Jan 30, 2018 Coltene invests in Altstätten site The dental technology company Coltene will invest 11 million Swiss francs to modernize and enlarge its headquarters in Alstätten. The investment ...
News Jan 30, 2018 Roivant Sciences recognized with Tell Award The global healthcare company Roivant Sciences is a recipient of the 2017 Tell Award in recognition of its significant investment in Basel, Switz...
News Jan 30, 2018 Leonardo DiCaprio invests in Lausanne-based start-up MindMaze The celebrity, known for both his leading roles in films like Titanic and Inception, and his environmental activism, has joined virtual reality c...
News Jan 30, 2018 Researchers make flame retardants environmentally friendly Hotel mattresses and plane seats are often coated with toxic flame retardants. Now, Empa chemists have developed a synthesis method for an enviro...
News Jan 30, 2018 New method could speed up blood tests Scientists at Roche and ETH Zurich have developed a new method for analysing liquids. In the future, physicians could perform complex blood or ur...
News Jan 30, 2018 Roche receives three important drug approvals The European Commission granted authorizations to three Roche therapies. They are for the treatment of giant cell arteritis, advanced follicular ...
News Jan 30, 2018 Johnson & Johnson expands biotech plant in Schaffhausen Schaffhausen – The U.S. company Johnson & Johnson is investing 22 million Swiss francs into its Schaffhausen site. Its subsidiary Cilag AG wi...
News Jan 30, 2018 Evolva awarded contract from U.S. government The ingredient manufacturer Evolva has been awarded a contract by the U.S. government to develop a new form of protection against insects in an e...
News Jan 30, 2018 PARK INOVAARE draws in biotech startups More and more biotechnology startups are moving into PARK INOVAARE at the Paul Scherrer Institute. The facility now plans to develop further into...
News Jan 30, 2018 Michael N. Hall receives Lasker Award Michael N. Hall from the University of Basel’s Biozentrum is the sole recipient of this year’s Lasker Basic Medical Research Award. The biochemis...
News Jan 30, 2018 Euronext expanding to Zurich Euronext plans to open an office in Zurich to support technology companies. A leading pan-European exchange in the Eurozone, Euronext sees consid...
News Jan 30, 2018 Apple colours its headquarters with Aargau paint Apple ordered a total of 30 tonnes of paint from Monopol Colors in Fislisbach. A paint developed especially for the technology giant is now graci...
News Jan 30, 2018 Novartis gets green light for gene therapy The U.S. Food and Drug Administration FDA has approved Kymriah, a therapy developed by the Basel-based pharmaceutical giant Novartis to treat a t...
News Jan 30, 2018 Aurealis Pharma AG raises 5.6 million Swiss francs Aurealis Pharma AG has closed a 5.6 million Swiss franc financing round. Headquartered in Basel and Finland, the biotechnology company develops m...
News Jan 30, 2018 UZH Life Sciences Fund invests in bioengineered skin UZH Life Sciences Fund is investing 1 million Swiss francs into the Zurich-based startup CUTISS. The company has developed a technology that make...